1. Home
  2. RIOT vs CRSP Comparison

RIOT vs CRSP Comparison

Compare RIOT & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

N/A

Current Price

$13.05

Market Cap

5.2B

Sector

Technology

ML Signal

N/A

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$54.92

Market Cap

5.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RIOT
CRSP
Founded
2000
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
RIOT
CRSP
Price
$13.05
$54.92
Analyst Decision
Strong Buy
Buy
Analyst Count
13
19
Target Price
$26.21
$71.50
AVG Volume (30 Days)
17.9M
1.9M
Earning Date
10-30-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
693.97
N/A
EPS
0.40
N/A
Revenue
$637,162,000.00
$38,337,000.00
Revenue This Year
$79.35
N/A
Revenue Next Year
$13.31
$723.84
P/E Ratio
$33.49
N/A
Revenue Growth
103.62
N/A
52 Week Low
$6.19
$30.04
52 Week High
$23.94
$78.48

Technical Indicators

Market Signals
Indicator
RIOT
CRSP
Relative Strength Index (RSI) 34.54 46.09
Support Level $14.66 $55.52
Resistance Level $16.27 $59.25
Average True Range (ATR) 1.00 2.96
MACD -0.05 0.40
Stochastic Oscillator 4.05 45.59

Price Performance

Historical Comparison
RIOT
CRSP

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: